menu search

ANTX / AN2 Therapeutics: Boron Chemistry For Infectious Diseases

AN2 Therapeutics: Boron Chemistry For Infectious Diseases
AN2 is a developer of rare, infectious disease therapeutics. AN2 leverages its boron chemistry expertise and has a history of a successful sale to Pfizer. Read More
Posted: May 5 2023, 13:55
Author Name: Seeking Alpha
Views: 103184

ANTX News  

AN2 Therapeutics to Present New Data for Epetraborole at IDWeek 2023

By Business Wire
October 11, 2023

AN2 Therapeutics to Present New Data for Epetraborole at IDWeek 2023

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatment more_horizontal

Has AN2 Therapeutics (ANTX) Outpaced Other Medical Stocks This Year?

By Zacks Investment Research
September 11, 2023

Has AN2 Therapeutics (ANTX) Outpaced Other Medical Stocks This Year?

Here is how AN2 Therapeutics, Inc. (ANTX) and Artivion (AORT) have performed compared to their sector so far this year. more_horizontal

AN2 Therapeutics: Boron Chemistry For Infectious Diseases

By Seeking Alpha
May 5, 2023

AN2 Therapeutics: Boron Chemistry For Infectious Diseases

AN2 is a developer of rare, infectious disease therapeutics. AN2 leverages its boron chemistry expertise and has a history of a successful sale to Pfi more_horizontal

AN2 Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference

By GlobeNewsWire
August 29, 2022

AN2 Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference

MENLO PARK, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on dev more_horizontal

RA Capital-Backed AN2 Therapeutics Hits NASDAQ, With IPO Price At $15

By Benzinga
March 25, 2022

RA Capital-Backed AN2 Therapeutics Hits NASDAQ, With IPO Price At $15

AN2 Therapeutics Inc (NASDAQ: ANTX) will be offering 4.6 million shares at $15 a share in its initial public offering, under the ticker 'ANTX,' rais more_horizontal

AN2 Therapeutics Set for a March IPO

By Barrons
March 21, 2022

AN2 Therapeutics Set for a March IPO

Biotech AN2 Therapeutics will be the second company to go public through a traditional initial public offering in March. more_horizontal


Search within

Pages Search Results: